SIRAVEGNA, GIULIA
SIRAVEGNA, GIULIA
ONCOLOGIA
Abstract 2149: The anti-EGFR antibody mixture Sym004 overcomes acquired resistance to cetuximab in colorectal cancer
2016-01-01 Sanchez-Martin, Francisco J.; Dalmases, Alba; Bellosillo, Beatriz; Argiles, Guillem; Gelabert, Mariona; Cañadas, Israel; Vidal, Joana; Siravegna, Giulia; Arena, Sabrina; Koefoed, Klaus; Visa, Laura; Arpí, Oriol; Horak, Ivan D.; Iglesias, Mar; Stroh, Christopher; Kragh, Michael; Rovira, Ana; Albanell, Joan; Bardelli, Alberto; Tabernero, Josep; Montagut, Clara
Abstract B110: Heterogeneous genetic alterations emerge during acquired resistance to anti-EGFR therapy in colorectal cancer
2013-01-01 Arena, Sabrina; Misale, Sandra; Lamba, Simona; Siravegna, Giulia; Lallo, Alice; Hobor, Sebastijan; Russo, Mariangela; Buscarino, Michela; Sartore-Bianchi, Andrea; Bencardino, Katia; Amatu, Alessio; Siena, Salvatore; Di Nicolantonio, Federica; Bardelli, Alberto
Abstract B33: The oligoclonal antibody MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancer cells harboring EGFR extracellular domain mutations
2016-01-01 Arena, Sabrina; Siravegna, Giulia; Mussolin, Benedetta; Kearns, Jeffrey D.; Wolf, Beni B.; Misale, Sandra; Lazzari, Luca; Bertotti, Andrea; Trusolino, Livio; Adjei, Alex; Montagut, Clara; Nicolantonio, Federica Di; Nering, Rachel; Bardelli, Alberto
Abstract C94: Heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer are sensitive to concomitant inhibition of EGFR and MEK
2013-01-01 Misale, Sandra; Arena, Sabrina; Lamba, Simona; Siravegna, Giulia; Lallo, Alice; Hobor, Sebastijan; Russo, Mariangela; Buscarino, Michela; Sartore-Bianchi, Andrea; Bencardino, Katia; Amatu, Alessio; Siena, Salvatore; Di Nicolantonio, Federica; Bardelli, Alberto
Concomitant blockade of EGFR and MEK overcomes acquired resistance to anti-EGFR therapy in colorectal cancer cells and patients’ avatars
2014-01-01 Bardelli, Alberto; Misale, Sandra; Arena, Sabrina; Siravegna, Giulia; Lamba, Simona; Bencardino, Katia; Amatu, Alessio; Valtorta, Emanuele; Lauricella, Calogero; Sartore-Bianchi, Andrea; Di Nicolantonio, Federica; Siena, Salvatore
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells
2019-01-01 Amodio, V; Grmano, G; Barault, L; Lamba, S; Rospo, G; Magri, A; Maione, F; Crisafulli, G; Cancelliere, C; Lerda, G; Bartolini, A; Siravegna, G; Mussolin, B; Frappolli, R; Montone, M; Randon, G; de Braud, F; Angelozzi, NA; Marsoni, S; D'Incalci, M; Orlandi, A; Giraudo, E; Satore-Bianchi, A; Siena, S; Pietrantonio, F; Di Nicolantonio, F; Bardelli, A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Abstract 2149: The anti-EGFR antibody mixture Sym004 overcomes acquired resistance to cetuximab in colorectal cancer | 2016 | Sanchez-Martin, Francisco J.; Dalmases, Alba; Bellosillo, Beatriz; Argiles, Guillem; Gelabert, Mariona; Cañadas, Israel; Vidal, Joana; Siravegna, Giulia; Arena, Sabrina; Koefoed, Klaus; Visa, Laura; Arpí, Oriol; Horak, Ivan D.; Iglesias, Mar; Stroh, Christopher; Kragh, Michael; Rovira, Ana; Albanell, Joan; Bardelli, Alberto; Tabernero, Josep; Montagut, Clara | |
Abstract B110: Heterogeneous genetic alterations emerge during acquired resistance to anti-EGFR therapy in colorectal cancer | 2013 | Arena, Sabrina; Misale, Sandra; Lamba, Simona; Siravegna, Giulia; Lallo, Alice; Hobor, Sebastijan; Russo, Mariangela; Buscarino, Michela; Sartore-Bianchi, Andrea; Bencardino, Katia; Amatu, Alessio; Siena, Salvatore; Di Nicolantonio, Federica; Bardelli, Alberto | |
Abstract B33: The oligoclonal antibody MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancer cells harboring EGFR extracellular domain mutations | 2016 | Arena, Sabrina; Siravegna, Giulia; Mussolin, Benedetta; Kearns, Jeffrey D.; Wolf, Beni B.; Misale, Sandra; Lazzari, Luca; Bertotti, Andrea; Trusolino, Livio; Adjei, Alex; Montagut, Clara; Nicolantonio, Federica Di; Nering, Rachel; Bardelli, Alberto | |
Abstract C94: Heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer are sensitive to concomitant inhibition of EGFR and MEK | 2013 | Misale, Sandra; Arena, Sabrina; Lamba, Simona; Siravegna, Giulia; Lallo, Alice; Hobor, Sebastijan; Russo, Mariangela; Buscarino, Michela; Sartore-Bianchi, Andrea; Bencardino, Katia; Amatu, Alessio; Siena, Salvatore; Di Nicolantonio, Federica; Bardelli, Alberto | |
Concomitant blockade of EGFR and MEK overcomes acquired resistance to anti-EGFR therapy in colorectal cancer cells and patients’ avatars | 2014 | Bardelli, Alberto; Misale, Sandra; Arena, Sabrina; Siravegna, Giulia; Lamba, Simona; Bencardino, Katia; Amatu, Alessio; Valtorta, Emanuele; Lauricella, Calogero; Sartore-Bianchi, Andrea; Di Nicolantonio, Federica; Siena, Salvatore | |
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells | 2019 | Amodio, V; Grmano, G; Barault, L; Lamba, S; Rospo, G; Magri, A; Maione, F; Crisafulli, G; Cancelliere, C; Lerda, G; Bartolini, A; Siravegna, G; Mussolin, B; Frappolli, R; Montone, M; Randon, G; de Braud, F; Angelozzi, NA; Marsoni, S; D'Incalci, M; Orlandi, A; Giraudo, E; Satore-Bianchi, A; Siena, S; Pietrantonio, F; Di Nicolantonio, F; Bardelli, A |